Picture of SpectraCure AB (publ) logo

SPEC SpectraCure AB (publ) Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for SpectraCure AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-13.7-15.4-23.3-25.4-20.4
Depreciation
Non-Cash Items0.022.312.6833.56
Other Non-Cash Items
Changes in Working Capital1.53.692.06-0.578-1.8
Change in Accounts Receivable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-10.1-9.4-18.6-23-18.7
Capital Expenditures-15.1-10.6-8.49-10.1-15.8
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-1.230.205
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-15.1-10.6-8.49-11.3-15.6
Financing Cash Flow Items-1.34-15.11.800
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities34.3123-0.453-2.2-1.99
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash9.13103-27.5-36.5-36.2